Novel Bispecific CAR-T Cells Against Hematological Cancers

Dr. Vita Golubovskaya, Director of R&D at ProMab will be hosting a webinar with Agilent that incorporates some of our recent advancements in bispecific CAR-T cells.

April 7th, 2022

9:30 a.m. PT | 12:30p.m. ET